The World Market for Diagnostic Reagents and Opacifying Preparations for X-Ray Examinations: A 2024 Global Trade Perspective
This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for diagnostic reagents and opacifying preparations for X-ray examinations. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. Professor Philip M. Parker, the Chair Professor of Management Science at INSEAD, has developed a methodology, based on macroeconomic and trade models, to estimate the market for diagnostic reagents and opacifying preparations for X-ray examinations for those countries serving the world market via exports or supplying from various countries via imports. He does so for the current year based on a variety of key historical indicators and econometric models.
"Diagnostic reagents and opacifying preparations for X-ray examinations" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines "diagnostic reagents and opacifying preparations for X-ray examinations" is 54193.
- 1 METHODOLOGY
- 1.1 OUR APPROACH
- 2 THE WORLD MARKET
- 2.1 EXPORTS
- 2.1.1 THE WORLD MARKET: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS EXPORT SUPPLIES IN 2024
- 2.2 IMPORTS
- 2.2.1 THE WORLD MARKET: IMPORTED DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
- 3 EXPORTS
- 3.1 AFRICA: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
- 3.1.1 EXECUTIVE SUMMARY
- 3.1.2 ALGERIA
- 3.1.3 KENYA
- 3.1.4 MOROCCO
- 3.1.5 SOUTH AFRICA
- 3.2 ASIA: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
- 3.2.1 EXECUTIVE SUMMARY
- 3.2.2 CHINA
- 3.2.3 HONG KONG
- 3.2.4 INDIA
- 3.2.5 INDONESIA
- 3.2.6 JAPAN
- 3.2.7 MALAYSIA
- 3.2.8 NORTH KOREA
- 3.2.9 SINGAPORE
- 3.2.10 SOUTH KOREA
- 3.2.11 TAIWAN
- 3.2.12 THAILAND
- 3.3 EUROPE: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
- 3.3.1 EXECUTIVE SUMMARY
- 3.3.2 AUSTRIA
- 3.3.3 BELGIUM
- 3.3.4 BULGARIA
- 3.3.5 CROATIA
- 3.3.6 CYPRUS
- 3.3.7 DENMARK
- 3.3.8 FINLAND
- 3.3.9 FRANCE
- 3.3.10 GERMANY
- 3.3.11 GREECE
- 3.3.12 HUNGARY
- 3.3.13 IRELAND
- 3.3.14 ITALY
- 3.3.15 LATVIA
- 3.3.16 LITHUANIA
- 3.3.17 LUXEMBOURG
- 3.3.18 NORWAY
- 3.3.19 POLAND
- 3.3.20 PORTUGAL
- 3.3.21 ROMANIA
- 3.3.22 RUSSIA
- 3.3.23 SLOVAKIA
- 3.3.24 SLOVENIA
- 3.3.25 SPAIN
- 3.3.26 SWEDEN
- 3.3.27 SWITZERLAND
- 3.3.28 THE CZECH REPUBLIC
- 3.3.29 THE NETHERLANDS
- 3.3.30 THE UNITED KINGDOM
- 3.3.31 UKRAINE
- 3.4 LATIN AMERICA: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
- 3.4.1 EXECUTIVE SUMMARY
- 3.4.2 ARGENTINA
- 3.4.3 BRAZIL
- 3.4.4 CHILE
- 3.4.5 COLOMBIA
- 3.4.6 COSTA RICA
- 3.4.7 MEXICO
- 3.4.8 PANAMA
- 3.4.9 PARAGUAY
- 3.4.10 URUGUAY
- 3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
- 3.5.1 EXECUTIVE SUMMARY
- 3.5.2 CANADA
- 3.5.3 THE UNITED STATES
- 3.6 OCEANIA: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
- 3.6.1 EXECUTIVE SUMMARY
- 3.6.2 AUSTRALIA
- 3.6.3 NEW ZEALAND
- 3.7 THE MIDDLE EAST: EXPORT SUPPLIES OF DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IN 2024
- 3.7.1 EXECUTIVE SUMMARY
- 3.7.2 IRAN
- 3.7.3 ISRAEL
- 3.7.4 PAKISTAN
- 3.7.5 THE UNITED ARAB EMIRATES
- 3.7.6 TURKEY
- 4 IMPORTS
- 4.1 AFRICA: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
- 4.1.1 EXECUTIVE SUMMARY
- 4.1.2 ALGERIA
- 4.1.3 BENIN
- 4.1.4 BOTSWANA
- 4.1.5 BURKINA FASO
- 4.1.6 CAMEROON
- 4.1.7 COTE D'IVOIRE
- 4.1.8 EGYPT
- 4.1.9 ETHIOPIA
- 4.1.10 MADAGASCAR
- 4.1.11 MALAWI
- 4.1.12 MAURITANIA
- 4.1.13 MAURITIUS
- 4.1.14 MOROCCO
- 4.1.15 MOZAMBIQUE
- 4.1.16 NIGER
- 4.1.17 NIGERIA
- 4.1.18 RWANDA
- 4.1.19 SENEGAL
- 4.1.20 SIERRA LEONE
- 4.1.21 SOUTH AFRICA
- 4.1.22 TANZANIA
- 4.1.23 UGANDA
- 4.1.24 ZIMBABWE
- 4.2 ASIA: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
- 4.2.1 EXECUTIVE SUMMARY
- 4.2.2 BRUNEI
- 4.2.3 CHINA
- 4.2.4 HONG KONG
- 4.2.5 INDIA
- 4.2.6 INDONESIA
- 4.2.7 JAPAN
- 4.2.8 MACAU
- 4.2.9 MALAYSIA
- 4.2.10 MONGOLIA
- 4.2.11 NEPAL
- 4.2.12 SINGAPORE
- 4.2.13 SOUTH KOREA
- 4.2.14 SRI LANKA
- 4.2.15 TAIWAN
- 4.2.16 THAILAND
- 4.2.17 THE PHILIPPINES
- 4.2.18 VIETNAM
- 4.3 EUROPE: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
- 4.3.1 EXECUTIVE SUMMARY
- 4.3.2 AUSTRIA
- 4.3.3 BELARUS
- 4.3.4 BELGIUM
- 4.3.5 BOSNIA AND HERZEGOVINA
- 4.3.6 BULGARIA
- 4.3.7 CROATIA
- 4.3.8 CYPRUS
- 4.3.9 DENMARK
- 4.3.10 ESTONIA
- 4.3.11 FINLAND
- 4.3.12 FRANCE
- 4.3.13 GEORGIA
- 4.3.14 GERMANY
- 4.3.15 GREECE
- 4.3.16 HUNGARY
- 4.3.17 ICELAND
- 4.3.18 IRELAND
- 4.3.19 ITALY
- 4.3.20 KAZAKHSTAN
- 4.3.21 LATVIA
- 4.3.22 LITHUANIA
- 4.3.23 LUXEMBOURG
- 4.3.24 MACEDONIA
- 4.3.25 MALTA
- 4.3.26 MOLDOVA
- 4.3.27 NORWAY
- 4.3.28 POLAND
- 4.3.29 PORTUGAL
- 4.3.30 ROMANIA
- 4.3.31 RUSSIA
- 4.3.32 SLOVAKIA
- 4.3.33 SLOVENIA
- 4.3.34 SPAIN
- 4.3.35 SWEDEN
- 4.3.36 SWITZERLAND
- 4.3.37 THE CZECH REPUBLIC
- 4.3.38 THE NETHERLANDS
- 4.3.39 THE UNITED KINGDOM
- 4.3.40 UKRAINE
- 4.4 LATIN AMERICA: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
- 4.4.1 EXECUTIVE SUMMARY
- 4.4.2 ARGENTINA
- 4.4.3 BOLIVIA
- 4.4.4 BRAZIL
- 4.4.5 CHILE
- 4.4.6 COLOMBIA
- 4.4.7 ECUADOR
- 4.4.8 EL SALVADOR
- 4.4.9 GUATEMALA
- 4.4.10 HONDURAS
- 4.4.11 MEXICO
- 4.4.12 NICARAGUA
- 4.4.13 PANAMA
- 4.4.14 PARAGUAY
- 4.4.15 PERU
- 4.4.16 SURINAME
- 4.4.17 URUGUAY
- 4.5 NORTH AMERICA & THE CARIBBEAN: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
- 4.5.1 EXECUTIVE SUMMARY
- 4.5.2 ARUBA
- 4.5.3 BARBADOS
- 4.5.4 BERMUDA
- 4.5.5 CANADA
- 4.5.6 JAMAICA
- 4.5.7 THE DOMINICAN REPUBLIC
- 4.5.8 THE UNITED STATES
- 4.6 OCEANIA: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
- 4.6.1 EXECUTIVE SUMMARY
- 4.6.2 AUSTRALIA
- 4.6.3 FIJI
- 4.6.4 FRENCH POLYNESIA
- 4.6.5 NEW CALEDONIA
- 4.6.6 NEW ZEALAND
- 4.7 THE MIDDLE EAST: DIAGNOSTIC REAGENTS AND OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS IMPORTS IN 2024
- 4.7.1 EXECUTIVE SUMMARY
- 4.7.2 ARMENIA
- 4.7.3 AZERBAIJAN
- 4.7.4 BAHRAIN
- 4.7.5 ISRAEL
- 4.7.6 JORDAN
- 4.7.7 KUWAIT
- 4.7.8 LEBANON
- 4.7.9 OMAN
- 4.7.10 PAKISTAN
- 4.7.11 QATAR
- 4.7.12 TURKEY
- 4.7.13 YEMEN
- 5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
- 5.1 DISCLAIMERS & SAFE HARBOR
- 5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook